Trial Profile
The study of the optimal dose and effects on maternal and fetal of ondansetron in the prevention of hypotension during spinal anesthesia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Apr 2016
Price :
$35
*
At a glance
- Drugs Ondansetron (Primary)
- Indications Nausea and vomiting
- Focus Adverse reactions; Pharmacodynamics
- 13 Aug 2013 New trial record